Cargando…

Artesunate and sorafenib: Combinatorial inhibition of liver cancer cell growth

An antimalarial medication, artesunate (Art), has exhibited promising anticancer effects with excellent tolerability in various types of cancer, suggesting that it has the potential to be used in combination with sorafenib (Sora) in hepatocellular carcinoma (HCC) treatment. To determine the potency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hao, Xu, Kanghe, Pian, Guangzhe, Sun, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781774/ https://www.ncbi.nlm.nih.gov/pubmed/31611983 http://dx.doi.org/10.3892/ol.2019.10810

Ejemplares similares

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells
por: Vakhrusheva, Olesya, et al.
Publicado: (2022)

Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models
por: Chen, Ying-Jie, et al.
Publicado: (2022)

Artesunate Inhibits the Cell Growth in Colorectal Cancer by Promoting ROS-Dependent Cell Senescence and Autophagy
por: Huang, Zhiying, et al.
Publicado: (2022)

Artesunate induces apoptosis and autophagy in HCT116 colon cancer cells, and autophagy inhibition enhances the artesunate-induced apoptosis
por: Jiang, Feng, et al.
Publicado: (2018)

Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels
por: Okamoto, Hiroki, et al.
Publicado: (2023)

Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2
por: Zhang, Ping, et al.
Publicado: (2015)

Artesunate Regulates Neurite Outgrowth Inhibitor Protein B Receptor to Overcome Resistance to Sorafenib in Hepatocellular Carcinoma Cells
por: He, Wubin, et al.
Publicado: (2021)

Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib
por: Zhang, Rui, et al.
Publicado: (2019)

Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
por: Yang, Qu, et al.
Publicado: (2021)

Artesunate and Dihydroartemisinin Inhibit Rabies Virus Replication
por: Luo, Jun, et al.
Publicado: (2021)

Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis
por: Huang, Ming-Zhi, et al.
Publicado: (2020)

Artesunate induces apoptosis and inhibits the proliferation, stemness, and tumorigenesis of leukemia
por: Chen, Shengmei, et al.
Publicado: (2020)

Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells
por: Lv, Jian, et al.
Publicado: (2018)

Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence
por: Wei, Shupei, et al.
Publicado: (2019)

Artesunate, as an Hsp90 inhibitor, inhibits the proliferation of Burkitt’s lymphoma cells by inhibiting AKT and ERK
por: Yuan-Ce, Li, et al.
Publicado: (2023)

α‐Fetoprotein fragment synergizes with sorafenib to inhibit hepatoma cell growth and migration and promote the apoptosis
por: Wang, Qiujiao, et al.
Publicado: (2022)

Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma
por: YOKOTA, Shohei, et al.
Publicado: (2022)

Sorafenib inhibited cell growth through the MEK/ERK signaling pathway in acute promyelocytic leukemia cells
por: Zhang, Yunjie, et al.
Publicado: (2018)

Artesunate Suppresses the Growth of Lung Cancer Cells by Downregulating the AKT/Survivin Signaling Pathway
por: Zhang, Weiwei, et al.
Publicado: (2022)

Anaphylaxis to artesunate?
por: Dube, S. K., et al.
Publicado: (2012)

Evaluation of the liver targeting and anti‑liver cancer activity of artesunate‑loaded and glycyrrhetinic acid‑coated nanoparticles
por: Pan, Xu-Wang, et al.
Publicado: (2023)

Retraction to artesunate induces apoptosis and inhibits the proliferation, stemness, and tumorigenesis of leukemia
por: Chen, Shengmei, et al.
Publicado: (2022)

Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis
por: Markowitsch, Sascha D., et al.
Publicado: (2020)

Synergistic Inhibition of Angiogenesis by Artesunate and Captopril In Vitro and In Vivo
por: Krusche, Benjamin, et al.
Publicado: (2013)

Artesunate Abolishes Germinal Center B Cells and Inhibits Autoimmune Arthritis
por: Hou, Lifei, et al.
Publicado: (2014)

Artesunate Induces SKM-1 Cells Apoptosis by Inhibiting Hyperactive β-catenin Signaling Pathway
por: Xu, Na, et al.
Publicado: (2015)

Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines
por: Riedel, Matthias, et al.
Publicado: (2016)

Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition
por: YANG, YAN, et al.
Publicado: (2014)

Efficacy of transcatheter arterial chemoembolization combined with sorafenib in inhibiting tumor angiogenesis in a rabbit VX2 liver cancer model
por: Li, WeiZhi, et al.
Publicado: (2020)

Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells
por: Wang, Kang, et al.
Publicado: (2019)

TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
por: Ho, Victor, et al.
Publicado: (2015)

Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells
por: Liang, Laoqi, et al.
Publicado: (2023)

Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
por: Zhang, Yafei, et al.
Publicado: (2012)

Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells
por: Chen, Chi-Yuan, et al.
Publicado: (2020)

Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival
por: Wang, Fang, et al.
Publicado: (2018)

Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction
por: Zhao, Fuguang, et al.
Publicado: (2020)

Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma
por: Zheng, Min, et al.
Publicado: (2017)

Combinatorial growth of Si nanoribbons
por: Park, Tae-Eon, et al.
Publicado: (2011)

NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance
por: Emma, M R, et al.
Publicado: (2016)

Population Pharmacokinetics of Artesunate and Dihydroartemisinin following Intra-Rectal Dosing of Artesunate in Malaria Patients
por: Simpson, Julie A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_rr3guhoeb9t4t9dl0jdmjq07ag